Clinical management and impact of scarlet fever in the modern era: findings from a cross-sectional study of cases in London, 2018–2019 [PDF]
BMJ Open, 2021 Objectives In response to increasing incidence of scarlet fever and wider outbreaks of group A streptococcal infections in London, we aimed to characterise the epidemiology, symptoms, management and consequences of scarlet fever, and to identify factors ...
Basel Karo +8 more
doaj +2 more sources
Epidemiological changes of scarlet fever before, during and after the COVID-19 pandemic in Chongqing, China: a 19-year surveillance and prediction study [PDF]
BMC Public HealthBackground This study aimed to investigate the epidemiological changes in scarlet fever before, during and after the COVID-19 pandemic (2005–2023) and predict the incidence of the disease in 2024 and 2025 in Chongqing Municipality, Southwest China ...
Rui Wu +15 more
doaj +2 more sources
Scarlet fever in an adult patient: A challenging diagnosis in an airway emergency [PDF]
SAGE Open Medical Case Reports, 2021 Scarlet fever is essentially a childhood disease, although it may occur in all ages. Early diagnosis and treatment are essential in preventing the spread of infection and progression to life-threatening complications.
Luísa Conceição Martins Ferreira +4 more
doaj +2 more sources
Exposure to air pollution and scarlet fever resurgence in China: a six-year surveillance study [PDF]
Nature Communications, 2020 The reason for a re-emergence of scarlet fever in China remains unclear. Here the authors show that the number of scarlet fever cases surged in 2011 peaking in 2018, this correlates with an increase in NO2 and O3 but does not necessarily imply causation.
Yonghong Liu +19 more
doaj +2 more sources
Ongoing epidemic of scarlet fever in Shanghai and the emergence of M1UK lineage group A Streptococcus: a 14-year surveillance study across the COVID-19 pandemic periodResearch in context [PDF]
The Lancet Regional Health. Western PacificSummary: Background: The surge of group A Streptococcus (GAS) infections in regional countries warranted attention in the post-COVID-19 era. The resurgence of notifiable scarlet fever in China has been a public health issue since 2011.
Jiehao Cai +7 more
doaj +2 more sources
Epidemiology of Reemerging Scarlet Fever, Hong Kong, 2005-2015. [PDF]
Emerg Infect Dis, 2017 The annual incidence rate of scarlet fever in Hong Kong remained elevated after an upsurge in 2011, increasing from 3.3 per 10,000 children aged ≤5 years during 2005–2010 to 18.1 during 2012–2015.
Lee CF, Cowling BJ, Lau EHY.
europepmc +3 more sources
EBioMedicine, 2018 From 2011, Hong Kong and mainland China have witnessed a sharp increase in reported cases, with subsequent reports of epidemic scarlet fever in North Asia and the United Kingdom. Here we examine epidemiological data and investigate the genomic context of
Yuanhai You +5 more
doaj +3 more sources
Increasing Number of Scarlet Fever Cases, South Korea, 2011–2016 [PDF]
Emerging Infectious Diseases, 2018 The increasing number of reported scarlet fever cases during 2011‒2016 in the National Notifiable Infectious Disease database in South Korea occurred because of increased overall reporting and expanded reporting criteria rather than because of increasing
Jong-Hun Kim, Hae-Kwan Cheong
doaj +2 more sources
Detecting spatio-temporal hotspots of scarlet fever in Taiwan with spatio-temporal Gi* statistic. [PDF]
PLoS ONE, 2019 A resurgence of scarlet fever has caused many pediatric infections in East Asia and the United Kingdom. Although scarlet fever in Taiwan has not been a notifiable infectious disease since 2007, the comprehensive national health insurance data can still ...
Jia-Hong Tang +2 more
doaj +2 more sources